 |
|
Evidence-Based Medicine Meets Cost-effectiveness Analysis
Carolyn M. Clancy, MD;
Douglas B. Kamerow, MD, MPH
JAMA. 1996;276(4):329-330.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
Accumulated public and private frustrations regarding escalating costs and substantial evidence of variation in medical practice have stimulated several parallel movements to narrow the gap between evidence and practice. Beginning with the work of the Canadian Task Force on the Periodic Health Examination1 and the US Preventive Services Task Force2 and followed by intense interest in the development and dissemination of clinical practice guidelines through a recent movement toward evidence-based medicine,3 there has been a proliferation of tools and methods to assess the value of medical interventions and translate those findings into practice. Once the province of a small group of social scientists, meta-analysis, decision sciences, and other methods are now familiar to an expanding cadre of clinician scientists struggling to apply scientific methods to improve routine practice. The opportunities for improvement are immense and fully worthy of the collective effort.4
See also p 285.
The
. . . [Full Text PDF of this Article]
Author Affiliations
From the Center for Primary Care Research (Dr Clancy) and the Office of the Forum for Quality and Effectiveness in Health Care (Dr Kamerow), Agency for Health Care Policy and Research, Rockville, Md.
Footnotes
Corresponding author: Carolyn M. Clancy, MD, Agency for Health Care Policy and Research, EOC 502, 2101 E Jefferson St, Rockville, MD 20852 (e-mail: cclancy@po3.ahcpr.gov).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
